(Q34307633)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22708601%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Cognitive dysfunction and depression in Parkinson's disease: what can be learned from rodent models? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22708601%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

cognitive dysfunction

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22708601%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Hanna S Lindgren

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22708601%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

1 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22708601%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Neuroscience

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22708601%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22708601%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22708601%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

1894-1907

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22708601%20AND%20SRC:MED&resulttype=core&format=json

Depression in Parkinson disease--epidemiology, mechanisms and management.

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Bilateral subthalamic stimulation impairs cognitive-motor performance in Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Impaired learning and memory in Pitx3 deficient aphakia mice: a genetic model for striatum-dependent cognitive symptoms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Intranigral LPS administration produces dopamine, glutathione but not behavioral impairment in comparison to MPTP and 6-OHDA neurotoxin models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

The role of the basal ganglia in implicit contextual learning: a study of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Treatment of depressive symptoms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

PITX3 polymorphism is associated with early onset Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Autosomal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Cognitive decline correlates with neuropathological stage in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Lesion of the substantia nigra, pars compacta impairs delayed alternation in a Y-maze in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Nonmotor symptoms in Parkinson's disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Associative plasticity in striatal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Behavioral recovery after transplantation into a rat model of Huntington's disease: dependence on anatomical connectivity and extensive postoperative training

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

A critical evaluation of the Braak staging scheme for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Cognitive dysfunction and dementia in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Neurotoxic in vivo models of Parkinson's disease recent advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

A highly reproducible rotenone model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Non-motor symptoms of Parkinson's disease: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Striatal neuroinflammation promotes Parkinsonism in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Systematic review of antidepressant therapies in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Dynamics of executive control and motor deficits in parkinsonian rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Exercise and Parkinson's: benefits for cognition and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Depression and Parkinson's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Spatial deficits in a mouse model of Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Neuroprotective effect of PACAP on translational control alteration and cognitive decline in MPTP parkinsonian mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Open-field bheavior in the rat: what does it mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Parkinson disease: the enteric nervous system spills its guts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Behavioral and anatomical consequences of small intrastriatal injections of kainic acid in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) disrupts social memory/recognition processes in the male mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Olfaction in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Deficits in a lateralized associative learning task in dopamine-depleted rats with functional recovery by dopamine-rich transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Comparison of 6-hydroxydopamine-induced medial forebrain bundle and nigrostriatal terminal lesions in a lateralised nose-poking task in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Movement without dopamine: striatal dopamine is required to maintain but not to perform learned actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Cognitive deficits in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Neurotoxic lesions of ventrolateral but not anteromedial neostriatum in rats impair differential reinforcement of low rates (DRL) performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Medial prefrontal and neostriatal lesions disrupt performance in an operant delayed alternation task in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Frontal-striatal disconnection disrupts cognitive performance of the frontal-type in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

The transcription factor PITX3 is associated with sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

21 January 2018

Neurotoxicity of MPTP.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Sleep disturbances in Parkinson disease and their potential role in heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Olfactory dysfunction as a diagnostic marker for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

7-nitroindazole attenuates 6-hydroxydopamine-induced spatial learning deficits and dopamine neuron loss in a presymptomatic animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

The clinical significance of neuropsychological changes following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Effects of D-cycloserine on MPTP-induced behavioral and neurological changes: potential for treatment of Parkinson's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Effects of MK-801 on recognition and neurodegeneration in an MPTP-induced Parkinson's rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Multi-organ autonomic dysfunction in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Neuropsychological profile of patients with Parkinson's disease without dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Synuclein deposition and non-motor symptoms in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Parkinson's disease, pesticides and mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Topology of intrastriatal dopaminergic grafts determines functional and emotional outcome in neurotoxin-lesioned rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

The morbid anatomy of dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Dose-dependent loss of motor function after unilateral medial forebrain bundle rotenone lesion in rats: a cautionary note.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

A neostriatal habit learning system in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

The search for a curative cell therapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Mutations in NR4A2 associated with familial Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Cognitive deficits in the early stages of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Cognitive impairments associated with early Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Attention-modulating effects of cognitive enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Memory and executive function impairment predict dementia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Genetic mouse models of Parkinson's disease The state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Neuropsychological prediction of dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Pathological basis for neurotransmitter changes in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Psychopathological symptoms of depression in Parkinson's disease compared to major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Reduced calcium/calmodulin-dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP-treated mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Developments of a water-maze procedure for studying spatial learning in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Spatial learning in rats is impaired after degeneration of the nigrostriatal dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Cognitive profile of patients with newly diagnosed Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Animal models of neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Preclinical models: status of basic research in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Neurodegeneration and motor dysfunction in a conditional model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

The effect of striatal dopamine depletion and the adenosine A2A antagonist KW-6002 on reversal learning in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

The prefrontal cortex and working memory: physiology and brain imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

A Golgi study of human locus coeruleus in normal brains and in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

An effect of dopamine depletion on decision-making: the temporal coupling of deliberation and execution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

DJ-1-deficient mice show less TH-positive neurons in the ventral tegmental area and exhibit non-motoric behavioural impairments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Risk is in the air: an intranasal MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Acetylcholine actions in the dorsomedial striatum support the flexible shifting of response patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

A systematic review of prevalence studies of depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Measuring impulsivity in mice: the five-choice serial reaction time task

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Cognitive deficits and striato-frontal dopamine release in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Psychiatric aspects of Parkinson's disease--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Endurance training enhances BDNF release from the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

The domain of supervisory processes and temporal organization of behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Evaluation of reward processes in an animal model of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Selective noradrenergic vulnerability in α-synuclein transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Structure and function of declarative and nondeclarative memory systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Alternation behavior, spatial discrimination, and reversal disturbances following 6-hydroxydopamine lesions in the nucleus accumbens of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Benefits of physical exercise on executive functions in older people with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

The occurrence of depression in Parkinson's disease. A community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Cognitive changes in mice following moderate MPTP exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Rotenone, paraquat, and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

The orbitofrontal cortex: Neuronal activity in the behaving monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Reconsidering anhedonia in depression: lessons from translational neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Rule learning, visuospatial function and motor performance in the Hdh(Q92) knock-in mouse model of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Early onset deficits on the delayed alternation task in the Hdh(Q92) knock-in mouse model of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

The dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

6-hydroxy-dopamine induced degeneration of central monoamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

PARK6 is a common cause of familial parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Schizophrenia-relevant behaviors in a genetic mouse model of constitutive Nurr1 deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

MPTP lesion causes neuroinflammation and deficits in object recognition in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Parkinson's disease risk from ambient exposure to pesticides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Dopamine depletion, stimulation or blockade in the rat disrupts spatial navigation and locomotion dependent upon beacon or distal cues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Impairments in the acquisition, retention and selection of spatial navigation strategies after medial caudate-putamen lesions in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Intracerebral transplants and memory dysfunction: circuitry repair or functional level setting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Antidepressant-like properties of sarizotan in experimental Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Variable effects of chronic subcutaneous administration of rotenone on striatal histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Non-motor behavioural impairments in parkin-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Deficits in Feeding Behavior after Intraventricular Injection of 6-Hydroxydopamine in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X

Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2012.08162.X